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Abstract
Objective: Not only white blood cells but also platelets are being considered in inflammatory reactions from now on. Mean platelet volume (MPV) and 
neutrophil to lymphocyte ratio (NLR) have been shown to change in inflammatory diseases like myocardial infarction, stroke and implicated in psychiatric 
disorders nowadays. Our first aim is to investigate the relation of MPV and NLR with depression and secondly to assess if they change with the treatment of 
depression. Methods: Forty-nine patients diagnosed with major depressive disorder (MDD) and hospitalized in a university hospital psychiatry inpatient 
unit retrospectively included in the study. Control group consisted of 48 hospital workers with no known disease. Complete blood count, Hamilton Depression 
Rating Scale (HAM-D) and Clinical Global Impression-Severity Scale (CGI-S) scores at admission and at discharge were noted and compared for the patient 
group. Discussion: MPV of depressed patients was higher than controls. When we look at admission and discharge scores of clinical scales, decrement 
is statistically significant for both HAM-D and CGI-S. There was decline both in MPV and NLR which were both statistically significant. Conclusion: 
Decreasing MPV and NLR values with the treatment of depression confirm the involvement of inflammatory processes in the pathophysiology of depression.
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Introduction
Depression and inflammation prime and kindle each other. In this 
vicious circle, depression elevates inflammatory responses and 
inflammation raises depression in turn. Inflammation has been 
raised and blamed in a number of disorders like cardiac failure, 
renal dysfunction, diabetes mellitus, acute/chronic liver disease, 
cancer, chronic obstructive pulmonary disease (COPD), asthma, 
obstructive sleep apnea, acute infections, rheumatoid arthritis, 
multiple sclerosis, chronic pain, and psoriasis; each of these also 
features an elevated risk for depression1. Not only the white blood 
cells (neutrophils, lymphocytes, and monocytes) but also platelets 
have been shown to be in change in inflammatory processes. 
The following mechanisms have been suspected of the platelet 
abnormalities observed in major depression: increased plasma 
concentrations of 5-hydroxytryptamine (5-HT) and epinephrine 
in platelets, altered intraplatelet concentrations of monoamines 
and catecholamines, increased intraplatelet calcium mobilization, 
up-regulation of 5-HT2A receptors or α adrenoreceptors, down- 
regulation of 5-HT transporter number, alteration in second 
messenger signal transduction2. Mean platelet volume (MPV) is a 
machine-calculated measure of the average size of platelets detected 
in blood. MPV is usually included in blood tests routinely as a part 
of the complete blood count (CBC) by many laboratories today and 
its value is more and more reported among the standard parameters 
of CBC. A normal range of platelet volume is 6-11 fL, equivalent to 
spheres of 2.65 to 2.9 mm in diameter. It has been demonstrated that 
platelet size, measured as MPV, correlates with their reactivity. MPV is 
positively related to indices of platelet function including expression 
of glycoproteins Ib and IIb/IIIa receptors. There is an uprising interest 
on MPV as an independent risk factor for thrombotic disorders, 
including myocardial infarction (MI)3 and its prognosis4, coronary 
atherosclerosis5 and stroke6.
Higher values of MPV found in patients with MI and unstable 
angina as compared with those with stable angina or noncardiac 
chest pain, and elevated MPV has been accepted as an independent 
risk factor for MI and stroke. A raised MPV is associated with poor 
clinical outcome among survivors of MI. Also, a positive relationship 
between MPV and the severity of acute ischemic cerebrovascular 
events has been established. Since data have cumulated pointing 
that depression is associated with platelet activation, it has become 
obvious that the selective serotonin reuptake inhibitor (SSRI) effect 
of blocking serotonin reuptake occurs not only in nerve cells but also 
in platelets, which inhibits their activity2.
 Neutrophils act as chiefs in inflammatory processes. The 
neutrophil to lymphocyte ratio (NLR), which may be calculated 
from the whole blood cell count is a cheap, reproducible test and has 
been investigated as a novel biomarker for systemic inflammatory 
response. NLR has been issued as a remarkable inflammatory 
marker, and high NLR levels are associated with increased mortality 
in breast cancer7, colorectal cancer8, gastric cancer9. 
Therefore we chose MPV and NLR as inflammatory biomarkers 
and our first aim is to investigate the relation of MPV and NLR 
with depression and secondly to assess if they change with the 
treatment of depression.
Materials and methods
Patient selection
This is a single center, retrospective case-control study. Patients 
admitted to the Psychiatry Inpatient Unit of Bezmialem Vakif 
University diagnosed with major depressive disorder determined 
with the Structural Clinical Interview Device (SCID-I) according to 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 
between 2014-2016 was screened retrospectively. Psychiatry Inpatient 
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Unit database is based on the ICD-10 criteria, DSM-IV codes were 
given as reference. Diagnoses used are from the discharge records 
through which only F32 codes were selected according to ICD-10. 
This study was conducted according to the revised version of the 
Helsinki Declaration. The local ethics committee has approved the 
study. Demographic and clinical characteristics such as gender, age, 
duration of disease, co-morbid conditions, and other medical illness 
obtained from medical records of the patients were reviewed. 
Patients were eligible if they were (i) adults older than 18 years of 
age and (ii) diagnosed with major depressive disorder determined 
with the SCID-I according to DSM-IV. The exclusion criteria included 
(i) patients whose complete medical history could not be obtained, 
(ii) patients who had any other comorbid psychiatric disorder 
according to DSM-IV, and (iii) patients with a history of cardiac 
failure, renal dysfunction, diabetes mellitus, acute/chronic liver 
disease, cancer, any autoimmune disorder (e.g. rheumatoid arthritis, 
multiple sclerosis), chronic obstructive pulmonary disease (COPD), 
asthma, obstructive sleep apnea, psoriasis, or acute infections. All the 
patients underwent an electrocardiogram (ECG) examination, blood 
pressure measurement, and routine biochemistry tests [including 
glucose, urea, creatinine, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), lactate dehydrogenase (LDH), serum iron, 
total iron-binding capacity, cholesterol, and triglyceride] during their 
hospital stay. Of inpatients with complete history, 49 consecutive 
patients were included in the study.
Controls
The control group was prospectively formed from 48 healthy hospital 
workers with no known medical disease according to both self-
declaration and medical records. They were age and sex matched 
with the study group. They had no history of any psychiatric 
disorder. They were evaluated with the SCID-I10 according to 
DSM-IV by an experienced psychiatrist. All volunteers were free of 
any Axis-I psychiatric disorder and free of cardiac failure, renal 
dysfunction, diabetes mellitus, acute/chronic liver disease, cancer, 
any autoimmune disorder (e.g. rheumatoid arthritis, multiple 
sclerosis), COPD, asthma, obstructive sleep apnea, psoriasis or acute 
infections. Blood sample was taken from controls to analyse basic 
hemogram only.
Smokers are included both in the patient and control groups 
and patients could still smoke during inpatient stay.
Scales used
Structured Clinical Interwiev Device-I (SCID-I)
Structured Clinical Interview for DSM-IV (SCID-I)11, Turkish 
version10 translated by Corapcıoğlu et al. in 1999 was conducted by 
a trained interviewer.
Hamilton Depression Rating Scale (HAM-D)
 HAM-D is a standard scale based on psychiatrists’ assessments and 
was developed in the late 1950s to measure depressive symptoms. 
The scale was initially designed to obtain a total score based on 17 of 
its 21 items. The validity and reliability study of the Turkish version 
of the scale was done by Akdemir et al. in 2001. The test-retest 
reliability coefficient of the HAM-D was based on a 5-day interval 
was .85, with a Cronbach alpha coefficient of .75 and a split-half 
reliability coefficient of .76. Interrater reliability coefficients based 
on the independent ratings of four assessors were between .87 and 
.98.; therefore it was shown to be a valid and reliable tool in the 
assessment of clinical depression12.
Clinical Global Impression-Severity Scale (CGI-S)
CGI rating scales are commonly used to measure symptom severity, 
treatment response, and efficacy of treatment in patients with 
psychiatric disorders CGI-S is a 7-point scale that requires the 
clinician to rate the severity of the patient’s illness at the time of 
the assessment. The scores are; 1 = not ill; 2 = borderline ill; 3 = 
slightly ill; 4 = moderately ill; 5 = markedly ill; 6 = very much ill; 
7 = severely ill13.
The first entry and before discharge HAM-D, Clinic Global 
Impression Scale, CBC examinations for each patient from the 
inpatient care unit wer used for analysis.
Biochemical and haematological analyses
Usually, the first blood tests are done next day after admission to 
our units and the last one is done in the morning before hospital 
discharge. Blood samples were drawn for all patients between 8 
and 9 a.m. after 12 hours of overnight fasting. Immediately 
after collecting blood samples, CBC was determined using Sysmex 
XS-1000iTM Automated
Hematology Analyzer (Sysmex, USA). The following platelet 
parameters were measured: PLT (expressed in 103/mm3), MPV 
(expressed in fL) and neutrophil count (expressed in /ul), lymphocyte 
count (expressed in /ul), NLR and erythrocyte sedimentation rate 
(ESR) (expressed in mm/h).
Statistical analysis
Statistical analysis was performed using the Statistical Package for 
the Social Science version 21.0 (IBM SPSS Statistics; Armonk, NY, 
USA). Simple descriptive statistics (mean ± standard deviation) 
were generated for continuous variables. Kolmogorov-Smirnov test 
was used to evaluate the distribution of variables. Student’s t-test was 
used for continuous variables with normal distribution, and Mann-
Whitney U test was used for continuous variables without normal 
distribution. Chi-square test was used for categorical variables.
Paired t-test was used for repeated data in the patient group. 
Differences were considered significant at p< 0.05 for all the tests. 
The receiver operator characteristics (ROC) curve was plotted to 
verify the accuracy of MPV and NLR.
Results
The sociodemographic and clinical characteristics of participants 
are presented in Table 1.
Thirty-six female and 13 male patients were included in the 
patient group, the mean age was 40.86 (ranged between 18-76). More 
than half of participants eduated less than high school level 65.3% 
were married, 32.7% was smoking. Eighty-five point four percent of 
patients were in their first hospital stay, 18.8% of them had at least 
one suicide attempt during their life time. The mean duration of 
hospitalization was 27.6 days ranging from 10 to 54 days.
Thirty-six female and 12 male hospital workers were included in 
the control group, the mean age was 36.85. More than half of healthy 
controls were graduated from university. Fifty-eight point three 
percent was married. Thirty-five point four percent was smoking. 
There was no statistically significant difference in terms of age, sex, 
marital status and smoking between the patient and control groups. 
Educational level is higher in control group owing to participation 
of doctors and nurses.
We could not find any association with sociodemographic data 
(age, sex, marital status and smoking) obtained and severity of 
depression in the patient group.  
Comparisons of laboratory parameters between patients at 
admission and control group are given in Table 2. MPV value in 
patients with depression was 9.13 ± 2.1, MPV in controls were 
7.19 ± 1.84. Difference in MPV between patients and controls was 
statistically significant. 
However, difference in the NLR between patient and control 
groups did not reach statistical significance.
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Table 1. The sociodemographic and clinical characteristics of study population
Patient (n: 49) Control (n: 48) p value
Age 40.86 ± 14.7 36.85 ± 10.1 123
n % n %
Sex Female 36 73.5 36 75 .524
Male 13 36.5 12 25
Educational status Uneducated 2 4.1 0 0 .000
Primary school 5 10.2 7 14.6
Secondary school 27 55.1 8 16.7
High school 8 16.3 4 8.3
University 7 14.2 29 60.4
Marital status Single 11 22.4 17 35.4 .342
Married 32 65.3 28 58.3
Widowed 4 8.2 1 2.1
Divorced 2 4.1 2 4.2
Smoking No 33 67.3 31 64.6  .555
Yes 16 32.7 17 35.4
Number of hospitalizations 1 41 85.4
2 4 8.3
3 3 4.2
6 1 2.1
Suicide attempt 0 39 81.2
1 8 16.7
7 2 2.1
For age independent t-test; for other categorical variables chi-square test.
Table 2. Comparisons of the laboratory parameters at admission with 
control group
Laboratory 
Parameters
Mean ± SS P values
Patient Admission Control
Platelet (/ul) 239333 ± 52210 252611 ± 61048 .496
MPV (fl) 9.13 ± 2.13 7.19 ± 1.84 .000***
Neutrophil (/ul) 4537 ± 1606 4330 ± 1472 .700
Lymphocyte (/ul) 2130 ± 716 2186 ± 581 .331
NLR 2.29 ± 1.02 2.09 ± 0.95 .241
*p < 0.05; **p < 0.01; ***p < 0.001; independent t-test. 
MPV: mean platelet volume; NLR: neutrophil to lymphocyte ratio.
Table 3. Clinical scales and laboratory parameters at admission and at 
discharge
Clinical Scales 
and Laboratory 
Parameters
Mean ± SS P values
Admission Discharge
HAM-D 17.38 ± 6.37 6.88 ± 3.94 .000***
CGI-S 4.75 ± 1.00 2.79 ± 0.87 .000***
Platelet(/ul) 239333 ± 52210 236112 ± 62710 .582
MPV (fl) 9.13 ± 2.13 8.55 ± 1.47 .031*
Neutrophil (/ul) 4537 ± 1606 4118 ± 1496 .108
Lymphocyte (/ul) 2130 ± 716 2335 ± 628 .025*
NLR 2.29 ± 1.02 1.86 ± 0.81 .003**
ESR (mm/h) 12.55 ± 9.9 13.41 ± 12.9 .675
*p < 0.05; **p < 0.01; ***p < 0.001; paired t-test for parametric values; Wilcoxon test for 
nonparametric values.
HAM-D: Hamilton Depression Rating Scale; CGI-S: Clinical Global Impression-Severity Scale; 
MPV: mean platelet volume; NLR: neutrophil to lymphocyte ratio.
Comparisons for admission and discharge scores of clinical 
scales and parameters are shown in Table 3. Decrement is 
statistically significant for both HAM-D and CGI-S; meaning that 
patients had improved. There was a decline both in MPV and NLR 
which were statistically significant (p < 0.05). Lymphocyte count 
but not the neutrophil count increased significantly (p < 0.05), 
platelet count and ESR did not change radically.
The ROC curves for MPV and NLR is shown in Figure 1. For 
MPV, the area under the curve was 0.782; the sensitivity and 
specificity were 0.83% and 0.35% respectively. For NLR, the area 
under the curve was 0.553; the sensitivity and specificity were 
0.42% and 0.22%, respectively. Confidence interval for MPV was 
[0.690-0.874] and for NLR it was [0.436-0.674].
Figure 1. Receiver operator characteristics curve for MPV and NLR. 
AUC: area under the curve.
Discussion
There is some evidence that many psychiatric disorders are 
accompanied by activation of inflammatory and cell-mediated 
immune pathways, for example, mania, schizophrenia, post-
traumatic stress disorder (PTSD)14. In the 1990s, the first papers 
showing inflammation by increased levels of proinflammatory 
cytokines, such as IL-6 and acute phase proteins and immune 
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activation by increased levels of sIL-2Rs levels in acute and 
euthymic manic patients were published15,16. From the perspective of 
depression, three meta-analyses have highlighted proinflammatory 
cytokine differences between patients with major depressive disorder 
and controls, including interleukin-6 (IL-6), tumor necrosis factor-
alpha (TNF-α), IL-1b, the soluble IL-2 receptor, the IL-1 receptor 
antagonist (IL-1ra), and C-reactive protein 3 (CRP)17-19.
Multiple biomarkers may give us more accurate findings 
for inflammation in depression and the most linked ones are 
interleukins (mostly IL-6) and TNF-α. However these tests are 
expensive, there are limited laboratories working on these 
biomarkers and the standardization is low between them. In 
contrast, CBC is cost effective and have already been ordered 
for many patients during routine laboratory work-up before 
psychiatric diagnoses and to exclude some organic disorders 
during the psychiatric disease course. MPV and NLR can be 
obtained from CBC and used as systemic inflammatory markers 
with increasing references2,4,6-9,14,20-22.
There are some studies using either MPV or NLR as biomarkers 
of inflammation in psychiatric disorders. In our study, we did 
not include the patients with other mental disorders or having 
any comorbidity with depression. In the literature, Wysokinski 
and Szczepocka studied comparisons of platelet parameters in 
schizophrenia, unipolar depression, and bipolar depression. They 
have found that patients with schizophrenia had the lowest mean 
number of platelets, while patients with unipolar depression had 
highest mean value. Patients with schizophrenia had the highest 
mean volume of platelets (MPV) and highest percentage of large 
platelets, while patients with bipolar depression had the lowest MPV 
and lowest percentage of large platelets23.
 In the study by Mayda et al., both MPV and NLR are used 
as inflammation biomarkers in acute mania. NLR increased 
similarly as in depression but MPV decreased and these findings 
may reflect inflammation and role of inflammation in the complex 
pathophysiology of acute mania21. As a different psychiatric 
disorder group neutrophils were found to be decreased in obsessive 
compulsive disorder (OCD) in a study comparing CBC parameters 
between patients with OCD and healthy controls24.
MPV and NLR values of patients were higher than healthy 
controls before the inpatient treatment of depression and they 
decreased with the treatment of depression supporting the 
involvement of inflammatory processes in the pathophysiology of 
depression. Our findings are in parallel with the results of other 
studies using MPV and NLR as markers for searching the relationship 
between inflammation and depression2,20,25. In the study by Ataoğlu 
et al., MPV was higher in patients with depression at baseline and 
decreased 8 weeks of treatment with escitalopram2. Red blood cell 
distribution width (RDW) and NLR was high in depression and 
decreased with treatment of depression in the study of Demircan 
et al.25. NLR was higher in depressed patients in other studies 
also20,25 and correlated with severity of depression, supposed to be 
an independent predictor of severe depression20. NLR may be a trait 
marker for suicidal vulnerability via a relationship between NLR and 
a recent suicide attempt in depressed inpatients. Future prospective 
studies are needed to determine the exact roles of NLR, and other 
inflammatory markers on suicidality in MDD26. NLR found to be 
higher in patients with major depression than those who had suicide 
attempts but the difference was not significant27. 
In MD, a later age of onset has not only been associated with 
inflammation, but also with atherosclerosis. While an earlier age of 
onset was associated with a family history of depression, a later age 
of onset was associated with a family history of vascular disease. 
NLR was related to a later onset of depression. Thus, in line with 
the vascular depression hypothesis as one distinct etiopathological 
mechanism, a later onset of depression is associated with pathological 
pathways relevant for cardiovascular disease has been supported28.
Although NLR was still higher in depressed patients than healthy 
controls, in our analysis we could not show a significant difference. 
In relation to the gender, we could not find difference between males 
and females with respect to NLR. It is hypothesized that females had 
a greater inflammatory response than males. In a study NLR was 
compared between sexes at baseline or at 12 weeks after treatment. 
Only females showed a significant increase in NLR after treatment, 
in keeping with increased neutrophil and decreased lymphocyte 
percentages. This finding is in contrast to a theory that decreased NLR 
occurs with response to treatment. An increased NLR may indicate 
that females show an inflammatory pattern in depression and may 
serve as a marker of depression with poorer prognosis29. In a recent 
metaanalysis subjects with major depressive disorder (MDD) had 
higher NLR as compared with healthy controls. Meta-regression 
analyses showed that the effect was not influenced by difference in 
male proportions and mean age30. 
From the perspective of sensitivity and specificity, in the ROC 
curve we found the area under the curve for MPV to be larger than 
it is for NLR (Figure 1). This finding may support MPV as being 
more sensitive and specific than NLR but this must be replicated 
in other studies.
High MPV increases cardiovascular disease risk, therefore some 
may consider that depression treatment may lessen the morbidity 
and mortality also. Platelets are known to have serotonin receptors, 
volume changes in platelets may have been caused by different levels 
or effects of serotonin associated with depression pathophysiology 
and treatment3.
In mice studies; larger, more frequent or more prolonged 
inflammatory responses have negative mental and physical health 
consequences1. The stronger associations in clinical samples 
compared with community samples provide evidence of dose-
response relationships18.
In our study, if we had analyzed MPV and NLR according to 
depression severity subgroups, it would be likely to see a higher 
level of inflammation than community because our sample is 
highly clinical with more severe depression within reason treated 
as inpatients.
Perhaps we can guess treatment response to antidepressant 
medications from MPV and NLR characteristics and personalize 
treatments in a similar way with the study by Uher et al. in which 
higher CRP levels were associated with a better response to 
nortriptyline than to escitalopram22. Baseline CRP levels were also 
detected to moderate the antidepressant  effects of a treatment that 
directly aims immune pathogenic mechanisms, which was beneficial 
only for individuals with high CRP levels16. Taken together, the 
evidence to date is agreeable with systematic inflammation working 
as a moderator of antidepressant response.
The strengths of our study, it combines more than one 
inflammation marker those could be derived from a CBC and high 
in depression. Limitations of our study are: this is a retrospective 
study so depression treatments were not standardized in contrast, 
personalized according to needs of patients in psychiatry ward. The 
study sample was relatively small to draw definite conclusions also 
antidepressant medications were bein actively used for depression 
when patients were in the outpatient setting. Moreover, most 
of the study population (75% of patients) was female; thus, our 
findings may not be generalized to each sex. Body mass index and 
blood pressure were not compared with the severity of depression. 
Larger, detailed prospective trials with patients who are free of any 
psychotropic medication are needed to establish the association 
between depression treatment and MPV, NLR.
Conclusion
Inflammation is a complex process involving several cells and 
molecules which may play a role in the pathophysiology of 
depression. MPV and NLR could be useful together with other 
clinical analyzes and evaluations in studies about MDD.
In future, perhaps we might be able to use MPV and NLR in 
patients with depression for diagnosis, treatment selection, prediction 
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of treatment response and long-term follow-up of depression so 
further studies need to be done in this field.
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